Intelligence / Healthtech / PMA Approvals / Medtronic Sofamor Danek USA, INC.
Approvalsdevice change approved (PMA)26 Aug 2026
Medtronic Sofamor Danek USA, INC.
26 Aug 2026: Device change approved (PMA) · INFUSE BONE GRAFT. Recorded in the openFDA device PMA data.
- Decided
- 26 Aug 2026
- Device
- INFUSE BONE GRAFT
- Specialty
- Orthopedic
- Type
- Supplement (Normal 180 Day Track)
- Reason
- Change Design/Components/Specifications/Material
- Reference
- P000054 S075
- Location
- Memphis, TN
What this signal means
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Medtronic Sofamor Danek USA, INC.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Medtronic Sofamor Danek USA, INC. in our registers.
29 OctMedtronic Sofamor Danek USA, Inc.device cleared · HealthtechApprovals26 AugMedtronic Sofamor Danek USA, INC.device change approved (PMA) · HealthtechApprovals21 OctMedtronic Sofamor Danek USA INCClass II recall · HealthtechQuality21 OctMedtronic Sofamor Danek USA INCClass II recall · HealthtechQuality
More in Orthopedic
PMA Approvals
22 SeptSpineart USA, INC.device change approved (PMA) · BAGUERA®C Cervical Disc ProsthesisApprovals21 SeptDepuy, INC.device change approved (PMA) · Attune Revision Knee SystemApprovals9 SeptCentinel Spine, LLCdevice change approved (PMA) · prodisc® C NovaApprovals26 AugMedtronic Sofamor Danek USA, INC.device change approved (PMA) · INFUSE BONE GRAFT/LT-CAGE LUMBAR TAPERED FUSION DEVICEApprovals
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.